Business
fromwww.theguardian.com
8 hours agoOzempic maker Novo Nordisk cuts sales and profit forecasts again
Novo Nordisk cut sales and profit forecasts due to slowed profit growth and intensifying competition in the GLP-1 obesity and diabetes market.